首页>
外国专利>
COMPOSITIONS, INCLUDING TAGASEROD IN SEPARATELY OR IN COMBINATION WITH A PROTON PUMP INHIBITOR, FOR TREATMENT OR PREVENTION OF GASTRONOMAL INJURIES
COMPOSITIONS, INCLUDING TAGASEROD IN SEPARATELY OR IN COMBINATION WITH A PROTON PUMP INHIBITOR, FOR TREATMENT OR PREVENTION OF GASTRONOMAL INJURIES
展开▼
机译:用于治疗或预防胃肠道损伤的组合物,包括他哥罗碱单独或与质子泵抑制剂组合使用
展开▼
页面导航
摘要
著录项
相似文献
摘要
1. A pharmaceutical composition comprising tegaserod and a proton pump inhibitor. ! 2. The pharmaceutical composition according to claim 1, wherein the proton pump inhibitor is selected from the group consisting of omeprazole, esomeprazole, lanzoprazole, rabeprazole, pantoprazole and leminoprazole. ! 3. The pharmaceutical composition according to claim 1, where the proton pump inhibitor is omeprazole. ! 4. A method of treating or preventing damage to the gastrointestinal tract in a subject in need of such treatment, comprising administering to the subject an effective amount of tegaserod. !5. The method according to claim 4, where damage to the gastrointestinal tract is induced by the administration of a non-steroidal anti-inflammatory drug (NSAID). ! 6. The method according to claim 4, where tegaserod is administered in combination with a proton pump inhibitor. ! 7. The method according to claim 6, where the proton pump inhibitor is selected from the group consisting of omeprazole, esomeprazole, lanzoprazole, rabeprazole, pantoprazole and leminoprazole. ! 8. The method according to claim 6, where the proton pump inhibitor is omeprazole. ! 9. The method according to claim 6, where tegaserod is first introduced, and then a proton pump inhibitor. ! 10. The method according to claim 6, where the proton pump inhibitor is first introduced, and then tegaserod. ! 11. The method according to claim 6, where tegaserod and a proton pump inhibitor are administered simultaneously. ! 12. The use according to claim 4, where the damage to the gastrointestinal tract is selected from the group including damage to the mucous membrane, dysfunction of the muscles of the gastrointestinal tract, gastritis, peptic erosion, ulcers and pathological changes in the gastrointestinal tract. ! 13. A method for treating pain and / or inflammation in a subject, comprising administering to a subject in need of such treatment a therapeutic
展开▼